Rothschild Investment LLC’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $721K | Sell |
8,699
-1,072
| -11% | -$88.9K | 0.05% | 264 |
|
|
2025
Q1 | $792K | Buy |
9,771
+116
| +1% | +$9.41K | 0.05% | 259 |
|
|
2024
Q4 | $870K | Buy |
9,655
+282
| +3% | +$25.4K | 0.06% | 257 |
|
|
2024
Q3 | $926K | Buy |
9,373
+4,595
| +96% | +$454K | 0.06% | 247 |
|
|
2024
Q2 | $443K | Buy |
4,778
+3,347
| +234% | +$310K | 0.03% | 353 |
|
|
2024
Q1 | $136K | Buy |
+1,431
| New | +$136K | 0.01% | 541 |
|
|
2017
Q2 | – | Sell |
-21,000
| Closed | -$1.46M | – | 486 |
|
|
2017
Q1 | $1.46M | Buy |
+21,000
| New | +$1.46M | 0.17% | 158 |
|